Deficiencies in essential vitamins and minerals (micronutrients) arising from poor quality diets are a major public health problem in low-and-middle-income countries (LMICs).

The PRINOGAM trial on the use of low doses of primaquine to interrupt malaria transmission from human to mosquitoes in individuals not sick but with a malaria infection has been successfully comple

We are excited to announce the release of our new quarterly newsletter, Our Science, and brochure that have now been posted on our website.

On Wednesday, April 6, 2016, Pfizer announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) approved a new four-dose, multi-dose vial (MDV) p

The launch of the MRC Unit The Gambia's 2016-2021 Quinquennial (5-year strategic plan) on the 1 April 2016 was successfully attended by over 400 staff, collaborators and partners.

The MRC Unit The Gambia (MRCG), has a long standing interest in tuberculosis (TB) occurring in households and has over the years maintained the TB research platform through core funding and a progr

The MRC Unit The Gambia (MRCG) will be hosting a ‘Bridging Biobanking and Biomedical Research across Europe and Africa’ (B3Africa) international workshop from 11-13 April 2016 at Kairaba Hotel.

Neonatal and early infant morbidity and mortality remains the highest in low and middle-income countries, often caused by infections that could be prevented by vaccines.

In an effort to improve our impact and position as a leader in health research and to address inconsistencies with the way our name and logo are used, we have revised our name to MRC Unit The Gambi

The MRC Unit The Gambia (MRCG), is internationally recognised for delivering excellent global health research in Africa and beyond.

The MRC Unit The Gambia (MRCG) is internationally recognised for its immense contribution in tackling infectious diseases of global public health importance in sub Saharan Africa.